BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12398773)

  • 1. Is insulin an endogenous cardioprotector?
    Das UN
    Crit Care; 2002 Oct; 6(5):389-93. PubMed ID: 12398773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin: an endogenous cardioprotector.
    Das UN
    Curr Opin Crit Care; 2003 Oct; 9(5):375-83. PubMed ID: 14508150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin in sepsis and septic shock.
    Das UN
    J Assoc Physicians India; 2003 Jul; 51():695-700. PubMed ID: 14621041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes.
    Dandona P; Chaudhuri A; Ghanim H; Mohanty P
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S25-34. PubMed ID: 17224874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hyperglycemia and insulin in acute coronary syndromes.
    Dandona P; Chaudhuri A; Ghanim H; Mohanty P
    Am J Cardiol; 2007 Jun; 99(11A):12H-18H. PubMed ID: 17665748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.
    Capes SE; Hunt D; Malmberg K; Gerstein HC
    Lancet; 2000 Mar; 355(9206):773-8. PubMed ID: 10711923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hyperglycaemia: a 'new' risk factor during myocardial infarction.
    Ceriello A
    Eur Heart J; 2005 Feb; 26(4):328-31. PubMed ID: 15618047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin in the critically ill with focus on cytokines, reactive oxygen species, HLA-DR expression.
    Das UN
    J Assoc Physicians India; 2007 Jul; 55 Suppl():56-65. PubMed ID: 17927013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose insulin in experimental myocardial infarction in rabbits: protection against effects of hyperglycaemia.
    Wong VW; Mardini M; Cheung NW; Mihailidou AS
    J Diabetes Complications; 2011; 25(2):122-8. PubMed ID: 20206553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting.
    Ceriello A; Zarich SW; Testa R
    J Am Coll Cardiol; 2009 Feb; 53(5 Suppl):S9-13. PubMed ID: 19179217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous glucose tolerance, insulin, glucose, and free fatty acid levels after myocardial infarction.
    Allison SP; Chamberlain MJ; Hinton P
    Br Med J; 1969 Dec; 4(5686):776-8. PubMed ID: 5359942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive management of hyperglycaemia in acute coronary syndromes. Study design and rationale of the BIOMArCS 2 glucose trial.
    de Mulder M; Umans VA; Stam F; Cornel JH; Oemrawsingh RM; Boersma E
    Diabet Med; 2011 Oct; 28(10):1168-75. PubMed ID: 21480974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction.
    Cheung NW; Wong VW; McLean M
    Diabetes Care; 2006 Apr; 29(4):765-70. PubMed ID: 16567812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction.
    Zarich SW; Nesto RW
    Circulation; 2007 May; 115(18):e436-9. PubMed ID: 17485582
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucose and insulin management in the post-MI setting.
    McNulty PH
    Curr Diab Rep; 2002 Feb; 2(1):37-44. PubMed ID: 12643121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial.
    de Mulder M; Umans VA; Cornel JH; van der Zant FM; Stam F; Oemrawsingh RM; Akkerhuis KM; Boersma E
    JAMA Intern Med; 2013 Nov; 173(20):1896-904. PubMed ID: 24018647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose normalization and outcomes in patients with acute myocardial infarction.
    Kosiborod M; Inzucchi SE; Krumholz HM; Masoudi FA; Goyal A; Xiao L; Jones PG; Fiske S; Spertus JA
    Arch Intern Med; 2009 Mar; 169(5):438-46. PubMed ID: 19273773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus.
    Bellodi G; Manicardi V; Malavasi V; Veneri L; Bernini G; Bossini P; Distefano S; Magnanini G; Muratori L; Rossi G
    Am J Cardiol; 1989 Oct; 64(14):885-8. PubMed ID: 2801556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hyperglycemia in patients with acute myocardial infarction.
    Ishihara M
    Circ J; 2012; 76(3):563-71. PubMed ID: 22293452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High plasma HDL-C attenuates stress hyperglycemia during acute phase of myocardial infarction.
    Carvalho LS; Cintra RM; Moura FA; Martins NV; Quinaglia E Silva JC; Coelho OR; Sposito AC;
    Atherosclerosis; 2012 Jan; 220(1):231-6. PubMed ID: 22018645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.